Sponsorship & Exhibits

ICNMD 2022 is an excellent opportunity to interact with a diverse group of clinicians, scientists, students, and industry professionals involved with muscular dystrophies, other myopathies, myasthenia gravis, polyneuropathies, spinal cord disorders, and neurofibromatosis, to list only a few.

Increase your visibility and organization’s exposure to the national and international markets by becoming a sponsor by holding an industry-supported symposium at this outstanding and important Congress.

The Congress is pleased to offer a variety of options, including but not limited to:

Industry-supported seminars
Print, digital and onsite advertising opportunities
Exhibit booths
and more…

To receive more details on how to sponsor our event, please fill out our Contact Form here.

Statistics on current and past ICNMD Congresses (click to expand)

Past Event Attendance

Year	Venue	Attendance	Year	Venue	Attendance
2022	Brussels, Belgium	1,200 exp.	2010	Naples, Italy	800
2021	Virtual, Worldwide	1,367	2006	Istanbul, Turkey	1,500
2018	Vienna, Austria	1,400	2002	Vancouver, Canada	900
2016	Toronto, Canada	800	1998	Adelaide, Australia	1,200
2014	Nice, France	900	1994	Kyoto, Japan	2,000

Demographics & Statistics

Regional statistics from past ICNMD editions:

ICNMD 2021 (Virtual, Worldwide)	ICNMD 2018 (Austria, Europe)	ICNMD 2016 (Canada, North America)	ICNMD 2014 (France, Europe)
Europe 59% North America 20% Latin America 8% Asia 8% Middle East & Africa 5%	Europe 66% North America 17% Asia 11% Middle East & Africa 4% Latin America 2%	North America 66% Europe 19% Asia 9% Middle East & Africa 3% Latin America 3%	Europe 66% North America 15% Asia 11% Middle East & Africa 4% Latin America 4%

Category statistics from past ICNMD editions:

ICNMD 2021 (Virtual, Worldwide)	ICNMD 2018 (Austria, Europe)	ICNMD 2016 (Canada, North America)
Healthcare Professionals 36% Industry 31% Academics * 31% Patient Organizations 1% Other 1%	Healthcare Professionals 36% Industry 33% Academics * 23% Patient organizations 1% Other 8%	Healthcare Professionals 40% Industry 33% Academics * 12% Patient organizations 7% Other 7%

* Some (most) of which are HCP

Past Sponsors & Exhibitors (click to expand)

Acceleron Pharma
Akashi Therapeutics
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Amylyx Pharmaceuticals
argenx
Astellas Gene Therapies
Biogen
BioMarin Pharmaceutical
Cadwell Industries
Canon/Toshiba Medical Systems
Cevidra
CSL Behring
CYTOO
EURO-NMD (European Reference Network for Neuromuscular Diseases)
European Neuromuscular Centre (ENMC)
Fulcrum Therapeutics
GBS Foundation of Canada
GBS/CIDP Foundation International
GE Healthcare
Genea Biocells
GeneDx
Grifols
Idera Pharmaceuticals
Italfarmaco

Journal of Neuromuscular Diseases
LFB Biomedicaments
LifeLabs Genetics
Lupin Neurosciences
MGZ - Medical Genetics Center
Muscular Dystrophy Canada
Myasthenia Gravis Society of Canada
Myositis/Myosite Canada
Novartis Gene Therapies
Octapharma
Pharnext
Pfizer
Philips Healthcare
PTC Therapeutics
Roche
RYR-1 Foundation
Sanofi Genzyme
Santhera Pharmaceuticals
Sarepta Therapeutics
SERB
Sigma-Tau Pharmaceuticals
Takeda Pharmaceuticals
Terumo BCT
TREAT-NMD
UCB Biopharma
Ultragenyx Pharmaceutical

Sponsorship & Exhibits Opportunities

The Congress is pleased to offer a variety of options, including but not limited to:

To receive more details on how to sponsor our event, please fill out our Contact Form here.

Statistics on Current and Past Editions

Past Event Attendance

Demographics & Statistics

Contact

Stay Connected